Cellestial Health raises €592K Pre-Seed round
8 May 2025· Cambridge, United Kingdom· health, pharmaceuticals, biotech, b2b, deep_hardware
The funding will be used to accelerate the development of novel therapeutics targeting astrocytes, with an initial focus on disease-modifying treatments for Parkinson's disease.
Investors
LeadZinc VC
Also participating
SFC CapitalAlma Angels
About Cellestial Health
Stage
Pre-Seed
Headquarters
Cambridge, United Kingdom
Founded
2023
Team Size
6–20
Sectors
healthpharmaceuticalsbiotechb2bdeep_hardware